US 10668055
Cancer treatment using combinations of ERK and RAF inhibitors
granted A61KA61K31/428A61K31/437
Quick answer
US patent 10668055 (Cancer treatment using combinations of ERK and RAF inhibitors) held by Biomed Valley Discoveries, Inc. expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Biomed Valley Discoveries, Inc.
- Grant date
- Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/428, A61K31/437, A61K31/44, A61K31/4439